IgA-nefropátia: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• BCMA 7
• CD19 8
• SGLT2 1
• CD20 0
• CD38 0
• IL-6 0
• JAK 0
• NLRP3 0
• TLR4 0
• mTOR 0
• STING 0
• IL-17 0
• AKT 0
• AMPK 0
• EGFR 0
• FAK 0
• GPX4 0
• HER2 0
• IL-1 0
• MET 0
• MYC 0
• NRF2 0
• PD-1 0
• PI3K 0
• STAT3 0
• TP53 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIDDK · R01

  Determination of structural features critical for nephritogenic properties of IgA1-containing immune complexes in IgA nephropathy

  University of Alabama at Birmingham· Birmingham, Egyesült Államok· 743 278 USD awarded in fiscal year 2026· until 2030. máj.

• NIH NIDDK · R01

  Dapagliflozin in Active Lupus Nephritis: A Pilot and Feasibility Randomized Trial

  Brigham and Women's Hospital· Boston, Egyesült Államok· 364 560 USD awarded in fiscal year 2026· until 2028. dec.

• NIH NIDDK · F32

  The Impact of APOL1 Copy Number Variation on Kidney Disease Susceptibility in African Americans

  Beth Israel Deaconess Medical Center· Boston, Egyesült Államok· 79 348 USD awarded in fiscal year 2026· until 2027. aug.

• NIH NIDDK · R01

  Interrogating The Biology Of Human Lupus Nephritis Using Single Cell Resolution Spatial Transcriptomics

  Seattle Children's Hospital· Seattle, Egyesült Államok· 801 241 USD awarded in fiscal year 2026· until 2028. jan.

• NIH NIAID · R01

  Contributions of autophagy-related genes in lupus

  Oklahoma Medical Research Foundation· Oklahoma City, Egyesült Államok· 751 755 USD awarded in fiscal year 2026· until 2027. júl.

• European Commission (Horizon Europe) · HORIZON-ERC

  Role of CD1c-reactive T cells and lipid antigens in post-streptococcal disease (CReativeLipid)

  The Chancellor, Masters and Scholars of the University of Oxford· Oxford, Egyesült Királyság· EU contribution 1 491 316 EUR· until 2030. szept.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Antigen-specific treatments to target autoimmune kidney diseases (AUTO-TARGET)

  Universitaetsklinikum Hamburg-Eppendorf· Hamburg, Németország· EU contribution 1 499 663 EUR· until 2030. márc.

• European Commission (Horizon Europe) · HORIZON-RIA

  Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology (geneTIGA)

  Charite - Universitaetsmedizin Berlin· Berlin, Németország· EU contribution 6 393 734 EUR· until 2026. dec.· 8 countries

8 of 22 running projects, newest first. Listed amounts together: 11,1 M USD + 9,4 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 6
• Mendelian Randomization Analysis 14
• Gene Expression Profiling 14
• Proteomics 8
• Metabolomics 5
• Flow Cytometry 2
• Immunohistochemistry 4
• Magnetic Resonance Imaging 1
• Machine Learning 9
• Deep Learning 3
• Cohort Studies 14
• Genome-Wide Association Study 20

• Cross-phenotype integration of eQTL-based Mendelian randomization and transcriptomics prioritizes BMP2K in IgA vasculitis with nephritis.

  Front Immunol, 2026. szept.

• Shared genetic architecture between Crohn's disease and IgA nephropathy: implications for a gut-immune-kidney axis.

  Front Immunol, 2026. aug.

• Male reproductive surgeries and long-term kidney outcomes: a Mendelian randomization and meta-analysis of UK Biobank and FinnGen.

  Ren Fail, 2026. aug.

• The causal effect of juvenile idiopathic arthritis on IgA nephropathy: A Mendelian randomization study.

  Medicine (Baltimore), 2026. jún.

• Causal effect between chronic periodontitis and IgA nephropathy: Insights from a 2-sample bidirectional Mendelian randomization study.

  Medicine (Baltimore), 2026. jún.

• Combination scRNA-seq with GWAS identifies genetic risk factors in IgA nephropathy: An observational study.

  Medicine (Baltimore), 2026. máj.

• Bidirectional Mendelian randomization study reveals no causal association between polycystic ovary syndrome and IgA nephropathy.

  Medicine (Baltimore), 2026. máj.

• Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomization.

  PLoS Comput Biol, 2026. ápr.

• Comprehensive Analysis of IgA Nephropathy Causal Factors in Plasma Proteins, Immune Cell Types, and Immune Cell Traits.

  Clin J Am Soc Nephrol, 2026. márc.

• Genetic risk factors in rheumatoid arthritis: A Mendelian randomization study of chronic kidney disease in European populations.

  Medicine (Baltimore), 2025. okt.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.